Huixin Li - Publications

Heterogeneity characterization and therapeutic marker discovery of endometrial carcinoma using GeoMXT™ digital spatial profiling.

Journal: Journal of translational medicine

Published: January 06, 2026

Applications of single-cell transcriptomics: updated insights in endometrial cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 13, 2025

Identification of a novel tRNA-derived small RNA fragment, tRF-16-2YU04DE, with the potential of inhibiting endometrial cancer progression.

Journal: Medical oncology (Northwood, London, England)

Published: January 17, 2025

Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer.

Journal: Translational cancer research

Published: February 03, 2024

3D-US and CBCT Dual-guided Radiotherapy for Postoperative Uterine Malignancy: A Primary Workflow Set-up.

Journal: Technology in cancer research & treatment

Published: November 23, 2023

CircABHD2 Inhibits Malignant Progression of Endometrial Cancer by Regulating NAD+/NAMPT Metabolism Axis.

Journal: Molecular biotechnology

Published: September 05, 2023

circNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis.

Journal: European journal of pharmacology

Published: August 31, 2023

tRF-20-S998LO9D inhibits endometrial carcinoma by upregulating SESN2.

Journal: Epigenomics

Published: February 21, 2023

Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma.

Journal: Frontiers in immunology

Published: January 16, 2023

Ovarian metastases from ALK-positive lung adenocarcinoma: a case report and review of the literature.

Journal: Translational cancer research

Published: February 08, 2022